REG - Norman Broadbent PLC - Director/PDMR Shareholding & Concert Party Update

Norman BroadbentAnnouncement

16/10/2020 13:00

RNS Number : 3638C
  
Norman Broadbent PLC
  
16 October 2020
  
 

Norman Broadbent plc
("Norman Broadbent", the "Company" or the "Group")
Director/PDMR Shareholding and Concert Party Update
Norman Broadbent (AIM: NBB) - a leading London listed Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces the following Shareholder updates below:
PDMR Dealings
Following the announcement on 5 October 2020 that the Company issued 1,333,333 ordinary shares to Angela Hickmore at a price of 5.25 pence per ordinary share as consideration for the Company's acquisition of Norman Broadbent Interim Management Limited, Angela's beneficial interest in the Company's ordinary shares is now 2.56%. 
 
Update regarding Concert Party
The Company provides an update on certain shareholders of the Company who have previously been presumed to be acting in concert under The Takeover Code (the "Concert Party") following a subscription and capital reorganisation of the Company in June 2010. Full details of the Concert Party were set out in the circular to Shareholders on 27 May 2010.
The Company announces that it has agreed with The Takeover Panel that Pierce Casey and Jonathan Moulton are no longer considered to be acting in concert. Pierce Casey currently holds 6,787,505 shares in the company (12.29% of issued share capital) and Jonathan Moulton holds 9,366,739 shares in the company (16.96% of issued share capital).
 
Total Voting Rights
The Company confirms it has a total of 55,218,903 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 55,218,903 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
 
In relation to the PDMR shareholding, further information is set out in the table below, one for each such purchase, in accordance with article 19(3) of the Market Abuse Regulation:



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name
 


Angela Hickmore




2
 


Reason for the notification
 




a)
 


Position/status
 


Senior executive




b)
 


Initial notification /Amendment
 


Initial Notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)
 


Name
 
 


Norman Broadbent plc




b)
 


LEI
 


213800E5YN5TA934XA23




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 




a)
 


Description of the financial instrument, type of instrument
 
Identification code
 


Ordinary Shares of £0.01 each
 
 
 
 
GB00B3VF4Y66




b)
 


Nature of the transaction


Consideration shares issued in relation to the acquisition of Norman Broadbent Interim Management Limited




c)
 


Price(s) and volume(s)


 



Price(s)
 


Volume(s)




5.25p


1,333,333 Ordinary Shares



 




d)
 


Aggregated information
 
- Aggregated volume
 
- Price 


 
 
 
N/A
 




e)
 


Date of the transaction


5 October 2020




f)
 


Place of the transaction


London, UK



 
Enquires:



Norman Broadbent plc








Mike Brennan
Steve Smith
 


020 7484 0000
 




WH Ireland Limited








Adrian Hadden
Jessica Cave
Darshan Patel
Matthew Chan


020 7220 1666



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCEAFEKFFAEFFA